Anti-lipopolysaccharide factor (32-51)[Y2A], L-2

General Information


DCTPep ID  DCTPep03758

Peptide Name   Anti-lipopolysaccharide factor (32-51)[Y2A], L-2

Sequence  HARIKPTFRRLKWKYKGKFW

Sequence Length  20

UniProt ID  P07086 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer therapy related peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  Not available

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C129H196N38O23

Absent amino acids  CDEMNQSV

Theoretical pI  11.76

Acidic residues  0

Basic residues  9

Polar residues  3

Molecular weight (Average)  2647.22

Molecular weight (Monoisotopic)  2645.53

Common amino acids  K

Net charge  9

Instability index (II)  23.56

Aliphatic index  44.00

Grand average of hydropathicity (GRAVY)  -1.315

Half Life 
  3.5 hours (mammalian reticulocytes, in vitro).
  10 min (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 12490
  Abs 0.1% (=1 g/l) 4.718

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 23401744

Title  The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells

Doi Not available

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12315

DCTPep is developed by Dr.Zheng's team.